相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bezafibrate and serum amyloid A–low-density lipoprotein complex in patients with type 2 diabetes mellitus and hypertriglyceridemia
Kazuhiko Kotani et al.
European Journal of Internal Medicine (2010)
Cardiovascular effects of leptin
Gary Sweeney
NATURE REVIEWS CARDIOLOGY (2010)
Management of the Metabolic Syndrome and Type 2 Diabetes Through Lifestyle Modification
Faidon Magkos et al.
Annual Review of Nutrition (2009)
A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome
Kazuhiko Kotani et al.
ATHEROSCLEROSIS (2009)
The effects of lifestyle modification on a new oxidized low-density lipoprotein marker, serum amyloid A-LDL, in subjects with primary lipid disorder
Kazuhiko Kotani et al.
CLINICA CHIMICA ACTA (2009)
Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome
Noriko Satoh et al.
HYPERTENSION RESEARCH (2009)
The LDL modification hypothesis of atherogenesis: an update
Daniel Steinberg
JOURNAL OF LIPID RESEARCH (2009)
Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk
Robert H. Knopp et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives
William S. Harris et al.
ATHEROSCLEROSIS (2008)
Fibrate Therapy An Update
Joshua Remick et al.
CARDIOLOGY IN REVIEW (2008)
The treatment of dyslipidemia - What's left in the pipeline?
Oliver Rau et al.
CHEMMEDCHEM (2008)
Evaluation of the Cardio-Ankle Vascular Index, a New Indicator of Arterial Stiffness Independent of Blood Pressure, in Obesity and Metabolic Syndrome
Noriko Satoh et al.
HYPERTENSION RESEARCH (2008)
Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome
Paul Holvoet et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Oxidized LDL and the metabolic syndrome
Paul Holvoet et al.
FUTURE LIPIDOLOGY (2008)
Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population
Haw-Wen Chen et al.
CARDIOLOGY (2008)
Measurement of plasma oxidized low-density lipoprotein and its clinical implications
Hiroyuki Itabe et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2007)
Treating the metabolic syndrome
Cristina Bianchi et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2007)
Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome
Noriko Satoh et al.
DIABETES CARE (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
HDL cholesterol transport during inflammation
Deneys R. van der Westhuyzen et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
A novel blood pressure-independent arterial wall stiffness parameter; Cardio-ankle vascular index (CAVI)
K Shirai et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2006)
Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy
SM Grundy
NATURE REVIEWS DRUG DISCOVERY (2006)
Clinical importance of the evaluation of blood non-HDL cholesterol levels in a hypercholesterolemia education class
Kazuhiko Kotani et al.
INTERNAL MEDICINE (2006)
Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population
C Meisinger et al.
CIRCULATION (2005)
Oxidized LDL and coronary heart disease
P Holvoet
ACTA CARDIOLOGICA (2004)
A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease
K Ogasawara et al.
ATHEROSCLEROSIS (2004)
Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study)
V Sigurdardottir et al.
JOURNAL OF INTERNAL MEDICINE (2002)
New criteria for 'obesity disease' in Japan
Y Matsuzawa et al.
CIRCULATION JOURNAL (2002)
Effects of simvastatin and atorvastatin on inflammation markers in plasma
O Wiklund et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Microarray analysis of gene expression changes in mouse liver induced by peroxisome proliferator activated receptor α agonists
K Yamazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
The oxidative modification hypothesis of atherosclerosis: Does it hold for humans?
JL Witztum et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2001)
Magnitude of sustained multiple risk factors for ischemic heart disease in Japanese employees - A case-control study
T Nakamura et al.
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION (2001)
Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia - Effects of bezafibrate therapy
FHAF de Man et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
